Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas D Shellenberger

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2008
Evaluation of geometric changes of parotid glands during head and neck cancer radiotherapy using daily MVCT and automatic deformable registrationChoonik Lee, Katja M Langen, Weiguo Lu, et al.
International Journal of Radiation Oncology, Biology, Physics|June 10, 2008
Assessment of parotid gland dose changes during head and neck cancer radiotherapy using daily megavoltage computed tomography and deformable image registrationChoonik Lee, Katja M Langen, Weiguo Lu, et al.
Head & Neck|April 11, 2009
Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinomaGary L Clayman, Thomas D Shellenberger, Lawrence E Ginsberg, et al.
Cancer Research|November 19, 2004
BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cellsThomas D Shellenberger, Mary Wang, Manu Gujrati, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2008
Evaluation of geometric changes of parotid glands during head and neck cancer radiotherapy using daily MVCT and automatic deformable registrationChoonik Lee, Katja M Langen, Weiguo Lu, et al.
International Journal of Radiation Oncology, Biology, Physics|June 10, 2008
Assessment of parotid gland dose changes during head and neck cancer radiotherapy using daily megavoltage computed tomography and deformable image registrationChoonik Lee, Katja M Langen, Weiguo Lu, et al.
Head & Neck|April 11, 2009
Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinomaGary L Clayman, Thomas D Shellenberger, Lawrence E Ginsberg, et al.
Cancer Research|November 19, 2004
BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cellsThomas D Shellenberger, Mary Wang, Manu Gujrati, et al.
Pageof 2